231. Vanstechelman F., Vandekerckhove H. Cytomegalovirus myocarditis in an immunocompetent patient // Acta Cardiol. 2012. Vol. 67, N 2. P. 257-260.
232. Venner C., Selton-Suty C., Huttin O. et al. Right ventricular dysfunction in patients with idiopathic dilated cardiomyopathy: prognostic value and predictive factors // Arch. Cardiovasc. Dis. 2016. Vol. 109, N 4. P. 231-241.
233. Vermes E., Childs H., Faris P., Friedrich M.G. Predictive value of CMR criteria for LV functional improvement in patients with acute myocarditis // Eur. Heart J. Cardiovasc. Imaging. 2014. Vol. 15, N 10. P. 1140-1144.
234. Vigneswaran T.V., Brown J.R., Breuer J., Burch M. Parvovirus B19 myocarditis in children: an observational study // Arch. Dis. Child. 2016. Vol. 101, N 2. P. 177-180.
235. von Landenberg P., Lehmann H.W., Modrow S. Human parvovirus B19 infection and antiphospholipid antibodies // Autoimmun. Rev. 2007. Vol. 6, N 5. P. 278-285.
236. Waldmüller S., Erdmann J., Binner P. et al. Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure // Eur. J. Heart Fail. 2011. Vol. 13, N 11. P. 1185-1192.
237. Walker A.M., Benson L.N., Wilson G.J., Arbus G.S. Cardiomyopathy: a late complication of hemolytic uremic syndrome // Pediatr. Nephrol. 1997. Vol. 11, N 2. P. 221-222.
238. Wang W., Guan H., Gerdes A.M. et al. Thyroid status, cardiac function, and mortality in patients with idiopathic dilated cardiomyopathy // J. Clin. Endocrinol. Metab. 2015. Vol. 100, N 8. P. 3210-3218.
239. Wang X., Zhang G., Liu F. et al. Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization // J. Clin. Virol. 2004. Vol. 31, N 1. P. 20-24.
240. Ward C., Ward A.M. Acquired valvular heart disease in patients who keep pet birds // Lancet. 1974. Vol. 2. P. 734.
241. Wolff G., Lin Y., Karathanos A. et al. Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials // Clin. Res. Cardiol. 2017. Vol. 106, N 7. P. 501-513.
242. Wurster T., Pölzelbauer C., Schönberger T. et al. Green fluorescent protein (GFP) color reporter gene visualizes parvovirus B19 non-structural segment 1 (NS1) transfected endothelial modification // PLoS One. 2012. Vol. 7, N 3. Article ID e33602.
243. Wyles S.P., Li X., Hrstka S.C. et al. Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells // Hum. Mol. Genet. 2016. Vol. 25, N 2. P. 254-265.
244. Xiong D., Lee G.H., Badorff C. et al. Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease // Nat. Med. 2002. Vol. 8, N 8. P. 872-877.
245. Yamamoto Y., Shirakabe A., Hata N. et al. Seasonal variation in patients with acute heart failure: prognostic impact of admission in the summer // Heart Vessels. 2015. Vol. 30, N 2. P. 193-203.
246. Yang J., Guo X., Yang J. et al. Myocardial damage in rats by suppressing TLR4-mediated signaling pathways. RP105 protects against apoptosis in ischemia/reperfusion-induced myocardial damage in rats by suppressing TLR4-mediated signaling pathways // Cell. Physiol. Biochem. 2015. Vol. 36, N 6. P. 2137-2148.
247. Yang Y., Lv J., Jiang S. et al. The emerging role of Toll-like receptor 4 in myocardial inflammation // Cell Death Dis. 2016. Vol. 7. P. e2234.
248. Yilmaz A., Mahrholdt H., Athanasiadis A. et al. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis // Heart. 2008. Vol. 94, N 11. P. 1456-1463.
249. Yokokawa M., Good E., Crawford T. et al. Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes // Heart Rhythm. 2013. Vol. 10, N 2. P. 172-175. pii: S1547-5271(12)01200-3.
250. Youn J.C., Shim H.S., Lee J.S. et al. Detailed pathologic evaluation on endomyocardial biopsy provides long-term prognostic information in patients with acute myocarditis // Cardiovasc. Pathol. 2014 Jan. pii: S1054-8807(14)00005-2.
251. Zee-Cheng C.S., Tsai C.C., Palmer D.C. et al. High incidence of myocarditis by endomyocardial biopsy in patients with idiopathic congestive cardiomyopathy // J. Am. Coll. Cardiol. 1984. Vol. 3, N 1. P. 63-70.
252. Zhang J., Zou C., Huang Y. et al. [Recovery and relapse of left ventricular systolic dysfunction in hospitalized patients with dilated cardiomyopathy: frequency and related factors] [Article in Chinese] // Zhonghua Xin Xue Guan Bing Za Zhi. 2015. Vol. 43, N 12. P. 1034-1039.
253. Zhao P., Sharma A.C., Ren J. Pathogenesis and therapy of autoimmunity-induced dilated cardiomyopathy // Front. Biosci. (Landmark Ed). 2009. Vol. 14. P. 1708-1715.
254. Zhu Y., Mao Z., Lou D., Zhang H. [The expression of connexin 43 and desmin in viral myocarditis] [Article in Chinese] // Zhonghua Bing Li Xue Za Zhi. 2000. Vol. 29, N 4. P. 288-290.
255. Zimmermann A.J., Bossard M., Aeschbacher S. et al. Effects of sinus rhythm maintenance on left heart function after electrical cardioversion of atrial fibrillation: implications for tachycardia-induced cardiomyopathy // Can. J. Cardiol. 2015. Vol. 31, N 1. P. 36-43.
256. Zimmermann O., Kochs M., Zwaka T.P. et al. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy // Int. J. Cardiol. 2005. Vol. 104, N 1. P. 92-100.
257. Zizek D., Cvijić M., Zupan I. et al. Cardiac resynchronization therapy in a patient with amyloid cardiomyopathy // Acta Cardiol. 2013. Vol. 68, N 3. P. 335-337.
258. Zubiaurre L., Zapata E., Bujanda L. et al. Cytomegalovirus hepatitis and myopericarditis // World J. Gastroenterol. 2007. Vol. 13, N 4. P. 647-648.